PapersFlow Research Brief
Smoking Behavior and Cessation
Research Guide
What is Smoking Behavior and Cessation?
Smoking behavior and cessation is the study of why people initiate, maintain, and relapse to tobacco smoking and of the interventions and policies that help smokers quit and sustain abstinence.
Smoking behavior and cessation is a large research area with 107,994 works in the provided dataset, spanning measurement of nicotine dependence, epidemiology of smoking-related harm, and evaluation of clinical and population-level interventions. "The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire" (1991) operationalized nicotine dependence with a refined questionnaire linked to biochemical measures of heaviness of smoking in 254 smokers. "Nicotine replacement therapy for smoking cessation" (2012) synthesized evidence that commercially available nicotine replacement therapies increase quitting success by 50% to 70% for people making a quit attempt.
Research Sub-Topics
Nicotine Dependence Assessment
This sub-topic focuses on the development, validation, and application of scales like the Fagerström Test for measuring nicotine dependence severity. Researchers study psychometric properties, cross-cultural adaptations, and predictive validity in cessation outcomes.
Nicotine Replacement Therapy
This sub-topic examines the efficacy, optimal dosing, and delivery methods of nicotine patches, gums, and inhalers for tobacco withdrawal. Researchers investigate combinations with behavioral therapies and long-term abstinence rates.
Mass Media Campaigns for Smoking Cessation
This sub-topic explores the design, reach, and impact of public health campaigns using TV, radio, and digital media to promote quitting. Researchers analyze cost-effectiveness, message framing, and population-level behavior change.
Smoking Cessation in Mental Illness
This sub-topic addresses elevated smoking rates and tailored interventions for individuals with schizophrenia, depression, and anxiety disorders. Researchers study integrated treatment models and barriers to dual recovery.
Adolescent Smoking Prevention
This sub-topic investigates school-based programs, policy interventions, and social influences to prevent tobacco initiation among youth. Researchers evaluate long-term effects using cohort studies and surveillance data.
Why It Matters
Smoking cessation has direct, measurable implications for mortality, health-care burden, and clinical decision-making. In long-term follow-up, "Mortality in relation to smoking: 40 years' observations on male British doctors" (1994) quantified hazards associated with long-term tobacco use using a prospective design with mortality tracked over 40 years, making smoking behavior a central target for prevention and treatment. At the population level, "Current Cigarette Smoking Among Adults — United States, 2005–2014" (2015) reported that tobacco smoking results in approximately 480,000 premature deaths and more than $300 billion in direct health care expenditures and productivity losses each year in the United States, providing a concrete basis for prioritizing cessation in health systems and policy. In clinical practice, "Nicotine replacement therapy for smoking cessation" (2012) concluded that multiple NRT forms (gum, patch, nasal spray, inhaler, lozenges/tablets) help people who attempt to quit, increasing quitting rates by 50% to 70%, which supports routine offering of pharmacotherapy alongside behavioral support. For targeted care, "Smoking and Mental Illness" (2000) highlighted that persons with mental illness are about twice as likely to smoke as other persons while still achieving substantial quit rates, motivating cessation services that are accessible within mental health settings rather than excluding these patients from treatment.
Reading Guide
Where to Start
Start with "Treating Tobacco Use and Dependence: 2008 Update" (2009) because it functions as an evidence-based clinical reference that orients readers to standard cessation treatments and care delivery.
Key Papers Explained
Measurement and mechanisms are anchored by Heatherton et al. (1991) in "The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire" (1991), which refines dependence assessment against biochemical correlates of heaviness of smoking in 254 smokers. Population harm is established by Doll et al. (1994) in "Mortality in relation to smoking: 40 years' observations on male British doctors" (1994), linking smoking habits to mortality over 40 years, and by Jamal et al. (2015) in "Current Cigarette Smoking Among Adults — United States, 2005–2014" (2015), which reports approximately 480,000 premature deaths and more than $300 billion in annual costs in the United States. Intervention efficacy is summarized by Stead et al. (2012) in "Nicotine replacement therapy for smoking cessation" (2012), which reports a 50%–70% increase in quitting rates with NRT, while Wakefield et al. (2010) in "Use of mass media campaigns to change health behaviour" (2010) provides a population-level behavior-change lens that complements clinical treatment.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Advanced work often integrates dependence measurement (e.g., FTND), targeted treatment for high-prevalence groups such as those described in "Smoking and Mental Illness" (2000), and population surveillance frameworks described in "Youth Risk Behavior Surveillance — United States, 2017" (2018) to evaluate real-world implementation of evidence-based cessation approaches described in "Treating Tobacco Use and Dependence: 2008 Update" (2009) and pharmacotherapy effects summarized in "Nicotine replacement therapy for smoking cessation" (2012).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Fagerström Test for Nicotine Dependence: a revision of the... | 1991 | British Journal of Add... | 10.6K | ✕ |
| 2 | Mortality in relation to smoking: 40 years' observations on ma... | 1994 | BMJ | 5.8K | ✓ |
| 3 | Treating Tobacco Use and Dependence: 2008 Update | 2009 | PsycEXTRA Dataset | 3.1K | ✓ |
| 4 | Protecting Adolescents From Harm | 1997 | JAMA | 2.7K | ✕ |
| 5 | Current Cigarette Smoking Among Adults - United States, 2016. | 2014 | PubMed | 2.6K | ✕ |
| 6 | Current Cigarette Smoking Among Adults — United States, 2005–2014 | 2015 | MMWR Morbidity and Mor... | 2.6K | ✕ |
| 7 | Smoking and Mental Illness | 2000 | JAMA | 2.5K | ✕ |
| 8 | Nicotine replacement therapy for smoking cessation | 2012 | Cochrane Database of S... | 2.5K | ✓ |
| 9 | Youth Risk Behavior Surveillance — United States, 2017 | 2018 | MMWR Surveillance Summ... | 2.5K | ✓ |
| 10 | Use of mass media campaigns to change health behaviour | 2010 | The Lancet | 2.4K | ✓ |
In the News
Achieve Life Sciences Announces FDA Acceptance of ...
*Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation*
FDA Accepts New Drug Application for Cytisinicline ...
* Cytisinicline's NDA acceptance by the FDA marks a potential breakthrough in smoking cessation treatment, with a PDUFA date set for June 20, 2026.
Efficacy of digital interventions for smoking cessation by type and method: a systematic review and network meta-analysis
## Abstract
High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to invite R01 applications to support new high-priority biomedical and behavioral research that will provide scientific data to inform th...
Looking to kick the habit? Islanders have options to quit ...
P.E.I.’s Smoking Cessation Program got its start in December 2019, and offers free nicotine replacement therapy to any resident.
Code & Tools
This repository hosts the Live without tobacco ("Viva sem Tabaco") project, the first open-source web-assisted intervention for smoking cessation. ...
Tobacco Cessation is an educational website that provides students in the Columbia College of Dental Medicine with multimedia learning modules on s...
## Repository files navigation A progressive Node.js framework for building efficient and scalable server-side applications. ## Description Nes...
SmokeFree is a Django-based web application to help users quit smoking by tracking cravings, providing AI-powered coaching, and supporting team-bas...
## Tools & Technologies
Recent Preprints
Efficacy of digital interventions for smoking cessation by ...
Smoking cessation is the only evidence-based approach to reducing tobacco-related health risks, yet traditional interventions suffer from limited coverage. Although digital interventions show promi...
The effectiveness of cognitive behavioral therapy for smoking cessation: A systematic review and meta-analysis
Cognitive Behavioral Therapy (CBT) is a commonly used intervention for smoking cessation. This PROSPERO-registered systematic review and meta-analysis (CRD42024581823) evaluated the long-term effec...
Cue-Restricted Smoking as a behavioral adjunct for ...
Cue-Restricted Smoking as a behavioral adjunct for smoking cessation: Observational sub-analysis of a randomized trial of deep transcranial magnetic stimulation Jaqueline R. Scholz 1 , Bi...
Understanding cigarette smoking and cessation among ...
Cigarette smoking is prevalent among adults with intellectual disability (ID), yet much remains to be understood about their smoking and cessation experiences, contributing to ongoing healthcare in...
Understanding perspectives on smoking cessation based ...
motivation. This study examines the role of Self-Determination Theory (SDT) in enhancing smoking cessation strategies by highlighting the significance of psychological needs for lasting behavioral ...
Latest Developments
Recent developments in smoking behavior and cessation research as of February 2026 include a high willingness among young adult nicotine users to quit, with about 67% planning to do so in 2026 (truthinitiative.org). Additionally, new national guidelines in Canada emphasize proven supports like counseling and nicotine replacement therapies over e-cigarettes for quitting (mcgill.ca), while recent studies suggest nicotine replacement therapies can significantly increase quitting success (smh.com). Advances also include evidence on digital interventions' efficacy and the ongoing evaluation of e-cigarettes, with systematic reviews indicating their potential benefits and limitations (nature.com, nejm.org).
Sources
Frequently Asked Questions
What is nicotine dependence and how is it measured in smoking-cessation research?
Nicotine dependence is commonly operationalized with brief standardized measures that capture behavioral intensity and urgency of smoking. "The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire" (1991) examined FTQ items against biochemical measures of heaviness of smoking in 254 smokers and refined the instrument into the FTND for dependence assessment.
How strongly is long-term smoking linked to mortality in cohort evidence?
Long-term cohort evidence links smoking habits to elevated mortality hazards over decades of follow-up. "Mortality in relation to smoking: 40 years' observations on male British doctors" (1994) followed male British doctors prospectively and assessed causes of death over 40 years, quantifying hazards associated with long-term tobacco use.
How effective is nicotine replacement therapy (NRT) for helping people quit smoking?
NRT is associated with higher quit success among people making a quit attempt across settings. "Nicotine replacement therapy for smoking cessation" (2012) concluded that commercially available NRT forms increase the rate of quitting by 50% to 70%, regardless of setting.
Which clinical guideline is most cited for treating tobacco use and dependence?
A widely cited clinical guideline is "Treating Tobacco Use and Dependence: 2008 Update" (2009). "Treating Tobacco Use and Dependence: 2008 Update" (2009) is commonly used as a reference point for evidence-based treatment recommendations in clinical cessation care.
Which populations require tailored cessation approaches due to higher smoking prevalence?
People with mental illness are a key population for tailored cessation services. Lasser et al. (2000) reported in "Smoking and Mental Illness" (2000) that persons with mental illness are about twice as likely to smoke as other persons but have substantial quit rates, supporting proactive cessation treatment in mental health care.
How are surveillance systems used to track smoking-related behaviors in youth and adults?
Surveillance systems quantify prevalence and trends to guide intervention priorities and evaluate progress. "Youth Risk Behavior Surveillance — United States, 2017" (2018) described how YRBSS data are used to compare prevalence across subpopulations, assess trends over time, and monitor progress toward national health objectives, while Jamal et al. (2015) in "Current Cigarette Smoking Among Adults — United States, 2005–2014" (2015) reported adult smoking indicators alongside burden estimates such as approximately 480,000 premature deaths and more than $300 billion in annual costs.
Open Research Questions
- ? Which specific FTND items (from "The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire" (1991)) best predict long-term cessation outcomes when paired with pharmacotherapy such as NRT described in "Nicotine replacement therapy for smoking cessation" (2012)?
- ? Which combinations of mass media strategies discussed in "Use of mass media campaigns to change health behaviour" (2010) most effectively translate into sustained reductions in adult cigarette smoking as monitored in "Current Cigarette Smoking Among Adults — United States, 2005–2014" (2015)?
- ? How should cessation interventions be adapted for people with mental illness given the higher smoking prevalence reported in "Smoking and Mental Illness" (2000) while maintaining comparable quit success?
- ? Which family, school, and individual protective factors identified in "Protecting Adolescents From Harm" (1997) best predict later smoking initiation patterns captured by surveillance approaches described in "Youth Risk Behavior Surveillance — United States, 2017" (2018)?
- ? How can clinical guideline recommendations summarized in "Treating Tobacco Use and Dependence: 2008 Update" (2009) be operationalized into scalable service models that deliver NRT effectiveness consistent with the 50%–70% quit-rate increase reported in "Nicotine replacement therapy for smoking cessation" (2012)?
Recent Trends
The provided dataset indicates a very large literature base (107,994 works) but does not provide a 5-year growth estimate (Growth (5yr): N/A), so trend claims cannot be quantified from the supplied metrics.
Within the highly cited core, recent emphasis includes scalable intervention strategies (e.g., "Use of mass media campaigns to change health behaviour" ) alongside pharmacotherapy synthesis showing consistent benefit across settings (Stead et al., "Nicotine replacement therapy for smoking cessation" (2012): 50%–70% higher quitting rates).
2010Surveillance-oriented papers such as "Youth Risk Behavior Surveillance — United States, 2017" and adult prevalence reporting in "Current Cigarette Smoking Among Adults — United States, 2005–2014" (2015) reflect ongoing prioritization of monitoring prevalence, disparities, and progress toward objectives using standardized systems.
2018Research Smoking Behavior and Cessation with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Smoking Behavior and Cessation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.